title: Acute severe asthma: Part 2. Current therapy.
abstract: Acute severe asthma is an extremely common and serious public health problem in the United States. Current optimum therapy of acute severe asthma includes supplemental oxygenation, nebulized beta-adrenergic receptor agonist therapy, and prompt use of glucocorticosteroids. In view of its low therapeutic index and the availability of more effective, less toxic agents, theophylline is no longer considered a first-line treatment. Ipratropium bromide combined with beta-agonist may augment bronchodilator responsiveness.
authors.affiliation: Texas College of Osteopathic Medicine (TCOM), Fort Worth.
authors.forename: R G
authors.initials: RG
authors.lastname: Garmon
authors.forename: R B
authors.initials: RB
authors.lastname: Zemenick
mesh_terms: D000208:Acute Disease; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006801:Humans; D009330:Nebulizers and Vaporizers; D010102:Oxygen Inhalation Therapy; D011247:Pregnancy; D012008:Recurrence
chemical_list: D000336:Aerosols